(ITW) Illinois Tool Works - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4523081093
Stock: Automotive Components, Food Equipment, Welding Equipment, Construction Fasteners, Specialty Packaging
Total Rating 56
Risk 83
Buy Signal -0.27
| Risk 5d forecast | |
|---|---|
| Volatility | 19.2% |
| Relative Tail Risk | -7.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | -1.67 |
| Character TTM | |
|---|---|
| Beta | 0.671 |
| Beta Downside | 0.922 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.63% |
| CAGR/Max DD | 0.45 |
EPS (Earnings per Share)
Revenue
Description: ITW Illinois Tool Works March 05, 2026
Illinois Tool Works Inc. (ITW) is a diversified global manufacturer of industrial products and equipment. The company operates across seven segments, serving a broad range of industrial and consumer markets.
Key segments include Automotive OEM, supplying components and fasteners to the automotive industry, and Food Equipment, a sector characterized by specialized machinery for commercial kitchens. The company also has significant operations in Welding, Construction Products, and Test & Measurement and Electronics, among others.
ITWs business model involves both direct sales to industrial manufacturers and distribution through independent channels. Its wide product portfolio and global reach are typical of large-cap industrial conglomerates. For more detailed financial metrics and segment performance, ValueRay offers in-depth analysis.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 3.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -2.11 > 1.0 |
| NWC/Revenue: 6.69% < 20% (prev 9.74%; Δ -3.04% < -1%) |
| CFO/TA 0.19 > 3% & CFO 3.13b > Net Income 3.07b |
| Net Debt (8.12b) to EBITDA (4.65b): 1.75 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (290.2m) vs 12m ago -1.89% < -2% |
| Gross Margin: 43.97% > 18% (prev 0.44%; Δ 4353 % > 0.5%) |
| Asset Turnover: 102.8% > 50% (prev 105.5%; Δ -2.72% > 0%) |
| Interest Coverage Ratio: 14.58 > 6 (EBITDA TTM 4.65b / Interest Expense TTM 292.0m) |
Altman Z'' 10.00
| A: 0.07 (Total Current Assets 6.20b - Total Current Liabilities 5.13b) / Total Assets 16.15b |
| B: 1.87 (Retained Earnings 30.15b / Total Assets 16.15b) |
| C: 0.27 (EBIT TTM 4.26b / Avg Total Assets 15.61b) |
| D: 2.19 (Book Value of Equity 28.33b / Total Liabilities 12.92b) |
| Altman-Z'' Score: 10.66 = AAA |
Beneish M -2.98
| DSRI: 1.03 (Receivables 3.23b/3.10b, Revenue 16.04b/15.90b) |
| GMI: 0.99 (GM 43.97% / 43.65%) |
| AQI: 1.04 (AQ_t 0.48 / AQ_t-1 0.46) |
| SGI: 1.01 (Revenue 16.04b / 15.90b) |
| TATA: -0.00 (NI 3.07b - CFO 3.13b) / TA 16.15b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of ITW shares?
As of March 05, 2026, the stock is trading at USD 287.17 with a total of 808,070 shares traded.
Over the past week, the price has changed by -0.89%, over one month by -0.56%, over three months by +15.90% and over the past year by +15.30%.
Over the past week, the price has changed by -0.89%, over one month by -0.56%, over three months by +15.90% and over the past year by +15.30%.
Is ITW a buy, sell or hold?
Illinois Tool Works has received a consensus analysts rating of 2.85.
Therefor, it is recommend to hold ITW.
- StrongBuy: 2
- Buy: 1
- Hold: 12
- Sell: 2
- StrongSell: 3
What are the forecasts/targets for the ITW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 279.8 | -2.6% |
| Analysts Target Price | 279.8 | -2.6% |
ITW Fundamental Data Overview March 05, 2026
P/E Trailing = 27.2362
P/E Forward = 25.5754
P/S = 5.1371
P/B = 26.0202
P/EG = 2.9592
Revenue TTM = 16.04b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 4.65b USD
Long Term Debt = 6.68b USD (from longTermDebt, last quarter)
Short Term Debt = 2.29b USD (from shortTermDebt, last quarter)
Debt = 8.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.12b USD (from netDebt column, last quarter)
Enterprise Value = 90.54b USD (82.42b + Debt 8.97b - CCE 851.0m)
Interest Coverage Ratio = 14.58 (Ebit TTM 4.26b / Interest Expense TTM 292.0m)
EV/FCF = 33.45x (Enterprise Value 90.54b / FCF TTM 2.71b)
FCF Yield = 2.99% (FCF TTM 2.71b / Enterprise Value 90.54b)
FCF Margin = 16.87% (FCF TTM 2.71b / Revenue TTM 16.04b)
Net Margin = 19.11% (Net Income TTM 3.07b / Revenue TTM 16.04b)
Gross Margin = 43.97% ((Revenue TTM 16.04b - Cost of Revenue TTM 8.99b) / Revenue TTM)
Gross Margin QoQ = 44.20% (prev 44.49%)
Tobins Q-Ratio = 5.61 (Enterprise Value 90.54b / Total Assets 16.15b)
Interest Expense / Debt = 0.84% (Interest Expense 75.0m / Debt 8.97b)
Taxrate = 22.85% (234.0m / 1.02b)
NOPAT = 3.28b (EBIT 4.26b * (1 - 22.85%))
Current Ratio = 1.21 (Total Current Assets 6.20b / Total Current Liabilities 5.13b)
Debt / Equity = 2.78 (Debt 8.97b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 1.75 (Net Debt 8.12b / EBITDA 4.65b)
Debt / FCF = 3.00 (Net Debt 8.12b / FCF TTM 2.71b)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.64% (Net Income 3.07b / Total Assets 16.15b)
RoE = 95.18% (Net Income TTM 3.07b / Total Stockholder Equity 3.22b)
RoCE = 42.99% (EBIT 4.26b / Capital Employed (Equity 3.22b + L.T.Debt 6.68b))
RoIC = 27.38% (NOPAT 3.28b / Invested Capital 12.00b)
WACC = 7.63% (E(82.42b)/V(91.39b) * Re(8.39%) + D(8.97b)/V(91.39b) * Rd(0.84%) * (1-Tc(0.23)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.83%
[DCF] Terminal Value 80.24% ; FCFF base≈2.76b ; Y1≈2.92b ; Y5≈3.46b
[DCF] Fair Price = 196.9 (EV 64.86b - Net Debt 8.12b = Equity 56.75b / Shares 288.2m; r=7.63% [WACC]; 5y FCF grow 6.29% → 2.90% )
EPS Correlation: 58.95 | EPS CAGR: 7.01% | SUE: 0.06 | # QB: 0
Revenue Correlation: 10.80 | Revenue CAGR: 1.03% | SUE: 0.75 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.80 | Chg7d=+0.001 | Chg30d=-0.022 | Revisions Net=-4 | Analysts=14
EPS current Year (2026-12-31): EPS=11.28 | Chg7d=+0.000 | Chg30d=+0.015 | Revisions Net=+3 | Growth EPS=+7.5% | Growth Revenue=+3.3%
EPS next Year (2027-12-31): EPS=12.12 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+7.5% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: -0.40 (3 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 8.4% - Earnings Yield 3.7%)
[Growth] Growth Spread = -1.6% (Analyst 3.1% - Implied 4.7%)
P/E Forward = 25.5754
P/S = 5.1371
P/B = 26.0202
P/EG = 2.9592
Revenue TTM = 16.04b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 4.65b USD
Long Term Debt = 6.68b USD (from longTermDebt, last quarter)
Short Term Debt = 2.29b USD (from shortTermDebt, last quarter)
Debt = 8.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.12b USD (from netDebt column, last quarter)
Enterprise Value = 90.54b USD (82.42b + Debt 8.97b - CCE 851.0m)
Interest Coverage Ratio = 14.58 (Ebit TTM 4.26b / Interest Expense TTM 292.0m)
EV/FCF = 33.45x (Enterprise Value 90.54b / FCF TTM 2.71b)
FCF Yield = 2.99% (FCF TTM 2.71b / Enterprise Value 90.54b)
FCF Margin = 16.87% (FCF TTM 2.71b / Revenue TTM 16.04b)
Net Margin = 19.11% (Net Income TTM 3.07b / Revenue TTM 16.04b)
Gross Margin = 43.97% ((Revenue TTM 16.04b - Cost of Revenue TTM 8.99b) / Revenue TTM)
Gross Margin QoQ = 44.20% (prev 44.49%)
Tobins Q-Ratio = 5.61 (Enterprise Value 90.54b / Total Assets 16.15b)
Interest Expense / Debt = 0.84% (Interest Expense 75.0m / Debt 8.97b)
Taxrate = 22.85% (234.0m / 1.02b)
NOPAT = 3.28b (EBIT 4.26b * (1 - 22.85%))
Current Ratio = 1.21 (Total Current Assets 6.20b / Total Current Liabilities 5.13b)
Debt / Equity = 2.78 (Debt 8.97b / totalStockholderEquity, last quarter 3.23b)
Debt / EBITDA = 1.75 (Net Debt 8.12b / EBITDA 4.65b)
Debt / FCF = 3.00 (Net Debt 8.12b / FCF TTM 2.71b)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.64% (Net Income 3.07b / Total Assets 16.15b)
RoE = 95.18% (Net Income TTM 3.07b / Total Stockholder Equity 3.22b)
RoCE = 42.99% (EBIT 4.26b / Capital Employed (Equity 3.22b + L.T.Debt 6.68b))
RoIC = 27.38% (NOPAT 3.28b / Invested Capital 12.00b)
WACC = 7.63% (E(82.42b)/V(91.39b) * Re(8.39%) + D(8.97b)/V(91.39b) * Rd(0.84%) * (1-Tc(0.23)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.83%
[DCF] Terminal Value 80.24% ; FCFF base≈2.76b ; Y1≈2.92b ; Y5≈3.46b
[DCF] Fair Price = 196.9 (EV 64.86b - Net Debt 8.12b = Equity 56.75b / Shares 288.2m; r=7.63% [WACC]; 5y FCF grow 6.29% → 2.90% )
EPS Correlation: 58.95 | EPS CAGR: 7.01% | SUE: 0.06 | # QB: 0
Revenue Correlation: 10.80 | Revenue CAGR: 1.03% | SUE: 0.75 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.80 | Chg7d=+0.001 | Chg30d=-0.022 | Revisions Net=-4 | Analysts=14
EPS current Year (2026-12-31): EPS=11.28 | Chg7d=+0.000 | Chg30d=+0.015 | Revisions Net=+3 | Growth EPS=+7.5% | Growth Revenue=+3.3%
EPS next Year (2027-12-31): EPS=12.12 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+7.5% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: -0.40 (3 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 8.4% - Earnings Yield 3.7%)
[Growth] Growth Spread = -1.6% (Analyst 3.1% - Implied 4.7%)